GLP-1 pills are coming, and they could revolutionize weight-loss …
Sep 17, 2024 · At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, with the most advanced now in the third and final stage of testing.
Expanding access to GLP-1 weight-loss drugs could save …
2 days ago · Two scenarios were considered: current uptake and expanded access. The current uptake rate of drugs among eligible persons with diabetes and obesity was parameterized as 13.6% and 10.8%, respectively.
Next-generation drug from Eli Lilly boosts weight loss to 24% ... - CNN
Jun 26, 2023 · Eli Lilly’s Mounjaro, cleared for type 2 diabetes and awaiting FDA approval for weight loss, targets both GLP-1 and a hormone called GIP, and has produced weight loss of 21 to 23%.
Beyond Ozempic: New GLP-1 drugs promise weight loss and …
On Thursday, ahead of the diabetes conference, Denmark-based biotech firm Zealand Pharma released data that showed a high dose of its experimental weight loss drug petrelintide helped reduce body...
Many people using GLP-1s for weight loss stop treatment too soon ... - CNN
May 21, 2024 · An analysis of health insurance claims released Tuesday found that most people using GLP-1 medications – about 58% – were on their treatment plan for less than 12 weeks, falling short of a key...
Science’s 2023 Breakthrough of the Year: Weight loss drugs
Dec 14, 2023 · The drugs mimic a gut hormone called glucagon-like peptide-1 (GLP-1), and they are reshaping medicine, popular culture, and even global stock markets in ways both electrifying and discomfiting. Originally developed for diabetes, these GLP-1 receptor agonists induce significant weight loss, with mostly manageable side effects.
FDA approves Eli Lilly’s Zepbound, a weight loss drug ... - NBC News
Nov 8, 2023 · The FDA has approved Zepbound, an injectable weight loss drug from Eli Lilly that helped people lose up to 52 lbs in 16 months during clinical trials.
Experimental drug could offer more weight loss than any drug ... - NBC News
Jun 26, 2023 · The new study underscores the rapid upswing in recent years in the discovery of new treatments for weight loss as companies invest in a new class of medicines called GLP-1 agonists, which...
After GLP-1, what’s next for weight loss? - Nature
Jun 6, 2023 · The GLP-1 agonist Wegovy has re-energized the hunt for obesity treatments. Alternatives — ranging from bitter taste compounds to lean muscle boosters and bacteria — are already in the clinic.
Considering GLP-1 medications? What they are and why lifestyle …
Losing weight can often be challenging. The good news is a class of medications called GLP-1 (glucagon-like peptide 1) agonists are emerging as true game changers, helping to control appetite and hunger, and allowing some people to shed pounds they’ve struggled to …